Usefulness of 18F-fluorodeoxyglucose-Positron Emission Tomography in Comparison with Methionine-Positron Emission Tomography in Differentiating Solid Hemangioblastoma from Adult Cerebellar Tumors

被引:0
作者
Takahashi, Yoshinobu [1 ]
Nishio, Akimasa [2 ]
Yamamoto, Daisuke [3 ]
Kamada, Hajime [2 ]
Hashimoto, Naoya [1 ]
机构
[1] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Neurosurg, Kyoto, Japan
[2] Hokuto Hosp, Dept Neurosurg, Obihiro, Hokkaido, Japan
[3] Hokuto Hosp, Dept Radiol, Obihiro, Hokkaido, Japan
关键词
18F-fluorodeoxyglucose; Hemangioblastoma; Methionine; Solid;
D O I
10.1016/j.wneu.2017.11.054
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BACKGROUND AND PURPOSE: Among adults with posterior fossa tumors, an intraaxial location of the tumor is less common than an extraaxial location. Moreover, the differential diagnosis of a single cerebellar tumor in adults is sometimes difficult by conventional magnetic resonance imaging. We aimed to report the findings of positron emission tomography (PET) using 18F-fluorodeoxyglucose (FDG) and methionine in adult patients with intraaxial and solitary metastatic brain tumors. MATERIALS AND METHODS: FDG-PET was performed on 12 patients with posterior fossa tumors: 4 had solid hemangioblastoma (HB), 3 had primary central nervous system lymphomas, 1 had a glioblastoma, and 4 had single metastatic brain tumors (METs). Methionine-PET was performed on 9 patients except for 1 patient with a MET. The maximum standardized uptake value (SUVmax) of the tumor was measured and compared with pathologic findings. RESULTS: The SUVmax of FDG in HB was lower compared with that of other tumors (P = 0.001). On the other hand, the SUVmax of methionine in the HB cases was almost the same as that in other tumors (P = 0.07). CONCLUSION: FDG-PET was helpful in differentiating HBs from adult cerebellar tumors.
引用
收藏
页码:E648 / E652
页数:5
相关论文
共 7 条
  • [1] Value of 11C-methionine PET in imaging brain tumours and metastases
    Glaudemans, Andor W. J. M.
    Enting, Roelien H.
    Heesters, Mart A. A. M.
    Dierckx, Rudi A. J. O.
    van Rheenen, Ronald W. J.
    Walenkamp, Annemiek M. E.
    Slart, Riemer H. J. A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (04) : 615 - 635
  • [2] HO VB, 1992, AM J NEURORADIOL, V13, P1343
  • [3] Central nervous system capillary haemangioblastoma: the pathologist's viewpoint
    Hussein, Mahmoud R.
    [J]. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2007, 88 (05) : 311 - 324
  • [4] Tryptophan metabolism in breast cancers: molecular imaging and immunohistochemistry studies
    Juhasz, Csaba
    Nahleh, Zeina
    Zitron, Ian
    Chugani, Diane C.
    Janabi, Majid Z.
    Bandyopadhyay, Sudeshna
    Ali-Fehmi, Rouba
    Mangner, Thomas J.
    Chakraborty, Pulak K.
    Mittal, Sandeep
    Muzik, Otto
    [J]. NUCLEAR MEDICINE AND BIOLOGY, 2012, 39 (07) : 926 - 932
  • [5] Kuhnt D, 2013, J NEUROSURG SCI, V57, P1
  • [6] 11C-Choline and F-18 FDG PET/CT Images of Hemangioblastoma
    Morooka, Miyako
    Ito, Kimiteru
    Kubota, Kazuo
    Hasuo, Kanehiro
    Okamoto, Koichiro
    Hara, Tetsuo
    [J]. CLINICAL NUCLEAR MEDICINE, 2011, 36 (02) : 143 - 144
  • [7] The rate-limiting step for tumor [18F]fluoro-2-deoxy-D-glucose (FDG) incorporation
    Smith, TAD
    [J]. NUCLEAR MEDICINE AND BIOLOGY, 2001, 28 (01) : 1 - 4